Skip to content
Open access

Insulin Efsitora Demonstrates Similar Efficacy and Safety Profiles to Insulin Icodec in Insulin‐Experienced Individuals With Type 2 Diabetes Mellitus: Matching‐Adjusted Indirect Comparisons of QWINT‐3 Versus ONWARDS 2, and QWINT‐4 Versus ONWARDS 4

Sep 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 10725 - 10735 · 0 citations · 37 references
Medicine

Abstract

To conduct indirect treatment comparisons (ITCs) of insulin efsitora alfa (efsitora) versus insulin icodec (icodec) in insulin‐experienced individuals with Type 2 Diabetes Mellitus.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.